靠寒武纪爆赚56亿元！超级牛散章建平，还买了哪些股票？｜股市会·牛散记

Core Viewpoint - The stock price of Cambrian Biologics reached a record high of 1587.91 yuan, surpassing Kweichow Moutai by 9.8%, marking a significant shift in the A-share market dynamics [1][2][3]. Stock Performance - On August 28, Cambrian Biologics' stock price peaked at 1595.88 yuan, closing at 1587.91 yuan, with a daily increase of 215.81 yuan or 15.73% [1][6]. - Kweichow Moutai, previously the "king" of A-shares, was dethroned by Cambrian Biologics [3]. Investor Insights - Notable investor Zhang Jianping, known as "Zhang the Leader," has gained significant attention due to his heavy investment in Cambrian Biologics, with a single-day profit exceeding 1.3 billion yuan [5][7]. - Zhang Jianping's total investment cost in Cambrian Biologics is estimated at around 4 billion yuan, with a current market value of approximately 9.66 billion yuan, resulting in a profit of about 5.66 billion yuan over four months [7][8]. Shareholding Structure - As of the latest report, Zhang Jianping holds 6.086 million shares of Cambrian Biologics, representing 1.46% of the total shares [6]. - The top shareholders include Chen Dashi with 28.63% and Beijing Zhongke Suanyuan Asset Management Co., Ltd. with 15.73% [6]. Other Investments by Zhang Jianping - Zhang Jianping has also invested in six other companies, with significant gains in four of them, including Huibo Yuntong (up 137%), Ningbo Huaxiang (up 104%), and Longxi Co. (up 147%) [9][10][11][18]. - Longyang Technology, another investment, has seen a gain of over 40% [15]. Company Profiles - Huibo Yuntong specializes in financial technology services, leveraging AI and big data for digital transformation in finance [12]. - Ningbo Huaxiang is a leading automotive parts manufacturer with ventures into humanoid robotics [12]. - Longxi Co. focuses on advanced materials for robotics, emphasizing self-lubricating technologies [13]. - Longyang Technology is involved in high-tech polymer films, with applications in optics and energy storage [17].